INS and diabetes mellitus: Diabetes is a complex clinical syndrome in which patients exhibit persistent hyperglycemia in the presence of reduced insulin secretion and sensitivity, causing aberrant metabolic changes, including an increased accumulation of advanced glycosylation end products and flux through the polyol and hexosaine (2.4-fold) pathways, as well as activation of protein kinase C isoforms [42,63].